| News and Events |
Source |
Date |
| J Med Chem Perspective: Allosteric Molulation of Seven Transmembrance Spanning Receptors is in the Top 20 Most Read Manuscripts for 2012. Click here to view paper. |
Group News |
Mar 1, 2012 |
| Congratulations to Dr. Craig Lindsley on receiving the 2013 Philip S. Portoghese Journal of Medicinal Chemistry/Division of Medicinal Chemistry Joint Lectureship (click here to read more) |
Group News |
Feb 26, 2013 |
| Money without collaboration won't bring cures |
Nature Medicine |
Feb 06, 2013 |
| Bristol, AZ take doses of Vanderbilt to treat depressed CNS drug R&D |
Fierce Biotech |
Jan 16, 2013 |
| AstraZeneca Collaborates with Vanderbilt - Analyst Blog |
NASDAQ |
Jan 16, 2013 |
| Vanderblt, AstraZeneca partner to identify candidate drug for major brain diseases |
News Medical.Net |
Jan 16, 2013 |
| AstraZeneca neuroscience unit inks deal with Vanderbilt University |
Boston Business Journal |
Jan 15, 2013 |
| Pharma companies partner with Vanderbilt on drug research in Franklin |
The Tennessean |
Jan 15, 2013 |
| AstraZeneca signs brain disorders pact with Vanderbilt |
Pharma Times |
Jan 15, 2013 |
| AstraZeneca and Vanderbilt University collaborate to develop novel treatments for major brain disorders |
AstraZeneca.com |
Jan 14, 2013 |
| AZ Licensing Vanderbilt Neuroscience Compounds |
GEN |
Jan 14, 2013 |
| AstraZeneca, VU collaborate to develop new treatments for major brain disorders |
The Reporter |
Jan 14, 2013 |
| Vanderbilt teaming with AstraZeneca to battle brain diseases |
The Tennessean |
Jan 14, 2013 |
Vanderbilt scores another neuroscience drug pact as AstraZeneca signs on
|
Fierce Biotech |
Jan 14, 2013 |
| AstraZeneca and Vanderbilt University Collaborate to Develop Novel Treatments for Major Brain Disorders |
Newswise |
Jan 14, 2013 |
| Congratulations to post-doctoral fellow, Dr. Joseph Panarese, Ph.D. on accepting a Drug Discovery Scientist position in VCNDD. |
Group News |
Jan 14, 2013 |
| Congratulations to post-doctoral fellow, Dr. Leah Konkol, Ph.D. on accepting a Drug Discovery Scientist position in VCNDD. |
Group News |
Jan 14, 2013 |
| Congratulations to Josh Brunner, M.S. 2012, on accepting the position of Business Development Manager at Triumvirate Enviroment. |
Group News |
Jan 8, 2013 |
| Congratulations to Mike Schulte, Ph.D. 2013, on accepting a postdoctoral position with Charles Manning in radiochemistry/imaging. |
Group News |
Dec 31, 2012 |
| BMS-Vanderbilt collaboration made the 2012 VUMC Highlghts |
The Reporter |
Dec 20, 2012 |
| Congratulations to Nate Daniels, Ph.D. 2010, then Feskik post-doc, on accepting an Assistant Professor position at Lipscomb University in the School of Pharmacy. |
Group News |
Dec 20, 2012 |
| (+)-Amabiline is the Top 20 most read papers in 2012. Click here to view paper. |
Group News |
Dec 17, 2012 |
| J Med Chem Perspective: Allosteric Molulation of Seven Transmembrance Spanning Receptors is in the Top 20 Most Read Manuscripts for 2012. Click here to view paper. |
Group News |
Dec 17, 2012 |
| The Top Prescription Drugs of 2012 paper is the most read ACS Chem Neuro paper in 2012 and one of the most highly accessed papers from the ACS in 2012. Click here to view paper. |
Group News |
Dec 17, 2012 |
| Congratulations to Mark Turlington, Ph.D. on accepting an Assistant Professor of Chemistry position at Berry College to start in Fall 2013. |
Group News |
Dec 10, 2012 |
| Congratulations to Cody Wenthur, who won 1st place in Best Overall Retreat Talk at the 2012 Fall Pharmacology Retreat - Paris Landing State Park, Buchanan, TN |
Group News |
Oct 23, 2012 |
| Bristol-Myers and Vanderbilt team up |
C&E News |
Oct 1, 2012 |
| Congratulations to Kris Hahn on accepting a medicinal chemist position at Cubist Pharmaceuticals, Inc. |
Group News |
Sept 24, 2012 |
| VU, Bristol-Myers to collaborate on Parkinson's therapies |
The Reporter |
Sept 21, 2012 |
| Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to
Develop Novel Treatments for Parkinson's Disease |
StreetInsider.com |
Sept 21, 2012 |
| Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to
Develop Novel Treatments for Parkinson's Disease |
BusinessWire |
Sept 21, 2012 |
| Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to Develop Novel Treatments for Parkinson’s Disease |
bms.com |
Sept 21, 2012 |
| Vanderbilt University and Bristol-Myers Squibb Sign Collaboration Agreement to
Develop Novel Treatments for Parkinson's Disease |
CNBC.com |
Sept 21, 2012 |
| Congratulations to Dr. Margrith Mattmann on accepting second post-doctoral positition at Sandford-Burnham Medical Research Insitute in the lab of Prof. Nicholas Cosford. |
Group News |
Sept 14, 2012 |
| Congratulations to Dr. Kim Lovell on accepting second post-doctoral positition at The Scripps Research Insitute in the lab of Prof. Laura Bohn. |
Group News |
August 30, 2012 |
| Muscarinic Receptor Agonists: Not Created Equal |
Schizophrenia Research Forum |
July 11, 2012 |
| Congratulations to Dr. Craig Lindsley on receiving an endowed chair, the William K. Warren, Jr. Chair in Medicine. |
Group News |
June 20, 2012 |
| (+)-Amabiline - named one of the journal's Top 20 most downloaded articles of the month. Click here to view paper. |
Group News |
April 24, 2012 |
| Minds wide open: Neuroscience at Vanderbilt |
Vanderbilt News |
April 6, 2012 |
| Congratulations to Dr. Sydney Stoops on accepting a post-doc position at the Scripps Research Institute in the Kodadek Lab. |
Group News |
Mar 28, 2012 |
| Tough Times for Neuroscience R&D |
C&E News |
Mar 19, 2012 |
| mGluR5 Ago-potentiator ADX-47273 - Top 10 most frequently cited ChemMedChem paper published in 2009/2010 and contributed most to the journal's 2011 impact factor. Click here to view paper. |
Group News |
Mar 13, 2012 |
| Allosteric Modulation of Seven Transmembrance spanning Receptors - Top 5 most read paper in J Med Chem in 2012 so far. Click here to view paper. |
Group News |
Mar 13, 2012 |
| Vanderbilt Spends $7.6 million to expand into Cool Springs Life Science Center |
The Tennessean |
Mar 8, 2012 |
| Center for Neuroscience Drug Discovery Expanding |
The Reporter |
Mar 8, 2012 |
| Pioneering Partnership with MJFF Drives New Parkinson's Treatment Toward Pharmacy Shelves |
Michael J. Fox Foundation |
Dec 13, 2011 |
| VCNDD Announces New Drug Candidates for Schizophrenia Entering Preparation for First-in-Human Clinical Testing |
VUMC News |
Dec 12, 2011 |
| VCNDD Announces New Drug Candidates for Schizophrenia Entering Preparation for First-in-Human Clinical Testing |
Medicine Health News Medsante |
Dec 12, 2011 |
| VCNDD Announces New Drug Candidates for Schizophrenia Entering Preparation for First-in-Human Clinical Testing |
Vanderbilt CTTC |
Dec 12, 2011 |
| VCNDD Announces New Drug Candidates for Schizophrenia Entering Preparation for First-in-Human Clinical Testing |
Newswise |
Dec 12, 2011 |
| Congratulations to Dr. Sydney Stoops on the successful Ph.D. defense |
Group News |
Dec 12, 2011 |
| In vitro and rat studies suggest mGluR4 positive allosteric modulators (PAMs) could be combined with existing PD therapies to treat PD. |
SciBX |
Dec 1, 2011 |
| Congratulations to Ms. Uyen Le on the successful defense of her MS thesis in Chemical & Physical Biology |
Group News |
Dec 1, 2011 |
| Vanderbilt forges path for academia |
Drug Discovery News |
Nov 25, 2011 |
| Studies on Parkinson's Drugs Blur Lines Between Academia and Industry |
InsideVandy.com |
Nov 8, 2011 |
| Congratulations to Patrick Gentry, the winner of both Best 1st Year Student Talk and Best Overall Retreat Talk at 2011 Annual Pharmacology Retreat - Lake Barkley State Resort |
Group News |
Nov 4, 2011 |
| Vanderbilt's Neuroscience Unit Operates Like a Biotech |
Elsevier Business Intelligence |
Oct 31, 2011 |
| Vanderbilt-Fox Foundation partnership yields drug-like molecules aimed at improving treatment of Parkinson's disease |
The Michael J. Fox |
Sept 30, 2011 |
| Vanderbilt-Fox Foundation partnership yields drug-like molecules aimed at improving treatment of Parkinson's disease |
Health Canal |
Sept 30, 2011 |
| Vanderbilt-Fox Foundation partnership yields drug-like molecules aimed at improving treatment of Parkinson's disease |
VUMC News |
Sept 29, 2011 |
| Vanderbilt researchers strive to refill drug discovery pipeline for Parkinson's disease, schizophrenia and fragile X syndrome |
Health Canal |
Sept 29, 2011 |
| Researcher strive to refill drug discovery 'pipeline' |
The Reporter |
Sept 29, 2011 |
| Vanderbilt researchers announce progress in treatments for some neurological conditions |
The Daily News Journal |
Sept 29, 2011 |
| Stealthy Karuna Licenses Schizophrenia Drugs from Vanderbilt |
Xconomy |
Sept 28, 2011 |
| Vanderbilt advances biotech partnerships |
C&E News |
Sept 26, 2011 |
| New drug-like molecules could improve schizophrenia treatment |
Vanderbilt News |
Sept 22, 2011 |
| VCNDD and State of the Medical Center Address |
The Reporter |
Sept 22, 2011 |
| New compounds may improve schizophrenia treatment |
Schizophrenic.com |
Sept 22, 2011 |
| Researchers at Vanderbilt and Karuna Pharmaceuticals develop drug-like molecules to improve schizophrenia treatment |
VUMC News |
Sept 21, 2011 |
| Researchers develop drug-like molecule to improve schizophrenia treatment |
Newswise |
Sept 21, 2011 |
| Autism spectrum drugs near clinical testing |
The Suncoast News |
Sept 21, 2011 |
| Karuna Pharmaceuticals targeting schizophrenia with new discoveries licensed from Vanderbilt University |
The Boston Globe |
Sept 20, 2011 |
| Potential new treatment for fragile X syndrome |
News Medical |
Sept 15, 2011 |
| Milestone in development of new treatment for 'fragile X' |
Vanderbilt News |
Sept 15, 2011 |
| Researchers with Vanderbilt, Seaside Therapeautics develop drug-like molecule to treat Fragile X |
The Daily News Journal |
Sept 15, 2011 |
| Big Pharma Finds a Home on Campus (pdf version click here) |
The Chronicle of Higher Education |
July 24, 2011 |
| Cancer study seeks clues to halting metastasis's march |
The Reporter |
July 21, 2011 |
| Niyi Fadeyi successfully defended his Ph.D. dissertation. Congratulations, Dr. Fadeyi! |
Group News |
June 17, 2011 |
| Congratulations to Matt O'Reilly. He has been selected as one of three recipients of a 2011-2012 ACS Medicinal Chemistry Fellowship. |
Group News |
May 27, 2011 |
| Craig Lindsley - Leadership of a Multi-investigator Team Award |
The Reporter |
May 25, 2011 |
| Congratulations to Leslie Aldrich on accepting a post-doc position at Broad Institute in the Schreiber Lab. |
Group News |
May 03, 2011 |
| Congratulations to Leslie Aldrich on receiving a P.E.O. (Philanthropic Educational Organization) Scholar Award |
Group News |
April 11, 2011 |
| Congratulations to Sydney Stoops on receiving a Stanford Graduate School of Business Summer Institute for Entrepreneurship (SIE) |
Group News |
April 01, 2011 |
| Congratulations to Niyi Fadeyi on receiving an UNCF-Merck Postdoctoral Science Research Fellowship |
Group News |
Mar 29, 2011 |
| VUMC scientists seek partners for neuro-drug discovery |
VNC |
Mar 21, 2011 |
| New drug discovery center focuses on brain disorders |
The Reporter |
Mar 10, 2011 |
| Scripps-Vanderbilt joint institute seeks to bridge med-chem gap |
Drug Discovery News |
Feb 08, 2011 |
| Drug Discovery at Vanderbilt |
Vanderbilt Medicine |
Jan 31, 2011 |
| A New Prescription for Drug Discovery |
Vanderbilt Medicine |
Jan 31, 2011 |
| VU, Scripps partner to advance science |
The Reporter |
Jan 20, 2011 |
| Vanderbilt, Scripps Research form partnership to open new institute |
The Medical News |
Jan 14, 2011 |
| Scripps, Vanderbilt Launch Biomedical Chemistry Institute |
GenomeWeb Daily News |
Jan 13, 2011 |
| Scripps Research and Vanderbilt Launch Joint Institute to Advance Science at Interface of Chemistry and Medicine |
Vanderbilt News |
Jan 13, 2011 |
| Changing Their Ways (pdf version click here) |
C&E News |
Dec 06, 2010 |
| Congratulations to Niyi Fadeyi on accepting a post-doc position at Harvard in the Shair Lab. |
Group News |
Aug 31, 2010 |
| Tom Bridges successfully defended his dissertation. Congratulations, Dr. Bridges! |
Group News |
Aug 17, 2010 |
| Phil Kennedy and Nate Daniels successfully defended their dissertations. Congratulations to Dr. Kennedy and Dr. Daniels! |
Group News |
July 29, 2010 |
| Brevisamide Paper is listed as one of the Organic Letters' Top 20 most read articles over the last 12 months. (click here to view paper ) |
Group News |
July 8, 2010 |
| Aziridine Paper is listed as one of the Organic Letters' Top 20 most read articles for the previous month. (click here to view paper ) |
Group News |
July 8, 2010 |
| Niyi Fadeyi won Best Poster at Gordon Conference on High Throughput Chemistry and Chemical Biology and is invited to present lecture at next year's GRC |
Group News |
Jun 21, 2010 |
| Lindsley lands award for translational pharmacology |
The Reporter |
Apr 15, 2010 |
| Message from the NIMH Director about the U01 Grant |
Inside NIMH |
Apr 08, 2010 |
| Craig Lindsley: Promotion to Full Professor! |
Group News |
Apr 05, 2010 |
| Novel grant supports drug discovery efforts |
The Reporter |
Mar 19, 2010 |
| Phil Kennedy, Ph.D. candidate, accepted post-doc position in Fesik's lab |
Group News |
Mar 15, 2010 |
| Nate Daniels, Ph.D. candidate, accepted post-doc position in Fesik's lab |
Group News |
Mar 01, 2010 |
| Nature Review DD Paper about Allosteric modulators of GPCRs has been selected by Thomson Reuters Science Watch® as a featured new hot paper in the field of Pharmacology & Toxicology! (click here to view paper ) |
ScienceWatch.com |
Jan 26, 2010 |
| ChemMedChem Paper about ADX-47273 was the 6th most accessed article in 2009! (click here to view paper ) |
Group News |
Jan 26, 2010 |
| Zebrafish swim into drug development (Breaking news from ACS Chemical Biology) |
Science Daily |
Jan 25, 2010 |
| Zebrafish swim into drug development |
Science Centric |
Jan 22, 2010 |
| Zebrafish swim into drug development |
The Reporter |
Jan 22, 2010 |
| Zebrafish swim into drug development |
EurekAlert! |
Jan 21, 2010 |
| Developmental disorders drug research bolstered |
The Reporter |
Jan 08, 2010 |
| Seaside Therapeutics and Vanderbilt University enter collaborative research agreement to discovery novel therapeutics to treat disorders of brain development |
CNBC |
Jan 06, 2010 |
| Craig Lindsley: 2010 ASPET-Astellas Award Winner |
aspet.org |
Dec 28, 2009 |
| Sydney Stoops passed Phase II Pharmacology qualifying exams |
Group News |
Dec 08, 2009 |
| Allosteric drugs promise precise control over diseases mediated by G-protein-coupled receptors |
C&E News |
Nov 23, 2009 |
| Niyi Fadeyi passed the Ph.D. Chemistry qualifying exam |
Group News |
Nov 11, 2009 |
| Investigators seek alternative to common diuretics |
The Reporter |
Nov 06, 2009 |
| Parkinson's disease research highlighted |
The Reporter |
Oct 23, 2009 |
| Leslie Aldrich passed the Ph.D. Chemistry qualifying exam |
Group News |
Oct 13, 2009 |
| Michael J. Fox Foundation-funded team pursuing glutamate-based treatment for Parkinson's disease hits major milestone |
Michael J. Fox Foundation |
Sep 30, 2009 |
| Michael J. Fox Foundation Q & A with Jeff Conn on his team's milestone in pursuit a glutamate-based therapy for Parkinson's disease |
Michael J. Fox Foundation |
Sep 30, 2009 |
| Targeting M1 - the Agony of Agonists, the Power of Potentiators |
Alzheimer Research Forum |
Aug 28, 2009 |
| Sydney Stoops passed Phase I Pharmacology qualifying exams |
Group News |
July 23, 2009 |
| Covering Neuroscience (pdf version click here) |
C&E News |
June 26, 2009 |
| First compound for receptors in schizophrenia and Alzheimer's... |
PHYSORG.Com |
Apr 20, 2009 |
| Covering Neuroscience (pdf version click here) |
C&E News |
Apr 20, 2009 |
| Compounds could be new class of cancer drugs |
Vanderbilt News |
Feb 4, 2009 |
| Compounds could be new class of cancer drugs |
RedOrbit |
Feb 3, 2009 |
| Vanderbilt forms pact with J&J (pdf version click here) |
C&E News |
Jan 19, 2009 |
| VU, Janssen team in drug discovery effort |
The Reporter |
Jan 16, 2009 |
| J&J-Vanderbilt in unusual schizophrenia drug deal |
Forbes |
Jan 09, 2009 |
| J&J, Vanderbilt team up on schizophrenia drugs |
The Wall Street Journal |
Jan 08, 2009 |
| Tom Bridges passed Phase II Pharmacology qualifying exam |
Group News |
Dec 17, 2008 |
| Phil Kennedy passed the Ph.D. Chemistry qualifying exam |
Group News |
Nov 10, 2008 |
| Nate Daniels passed the Ph.D. Chemistry qualifying exam |
Group News |
Oct 13, 2008 |
| Vanderbilt joins high-tech drug discovery effort |
The Reporter |
Sept 12, 2008 |
| NIH funds nine centers to speed application of powerful new research |
NIH News |
Sept 02, 2008 |
| Tom Bridges passed Phase I Pharmacology qualifying exam |
Group News |
August, 2008 |
| Grant bolsters ‘fragile X’ research |
The Reporter |
Feb 08, 2008 |
| $4.5 Million Drug Discovery Grant Awarded to Vanderbilt Medical Center |
Vanderbilt News |
Feb 04, 2008 |
| Grant helps spur pursuit of new Parkinson’s drugs |
The Reporter |
Dec 21, 2007 |
| Vanderbilt awarded $4.4 million by the Michael J. Fox Foundation |
Vanderbilt News |
Dec 18, 2007 |
| Pharmacology graduate student (Tom Bridges) wins award |
VICB News |
Oct 07, 2007 |
| Meet to explore chemistry of antibiotics chemistry |
The Reporter |
Aug 03, 2007 |
| Industry influx helps boost drug discovery capabilities |
The Reporter |
Jan 19, 2007 |
